We show that the landscape of recurrent glioblastoma is unique, wherein tumours display increased EGFR pathway expression without evidence of EGFR amplification, suggesting a phenotypic change not captured at the level of EGFR copy number or EGFR mRNA expression, arguing for an alternative mechanism for increased pathway activity. This evidence concerns the gene EGFR and glioblastoma.